|
2023-05-09 |
2023-05-05 |
A
Achat
|
BVF PARTNERS L P/IL
Actionnaire important
|
86 341
0,00
0 USD
|
86 341
|
0,00
|
0 USD
|
|
|
2023-05-09 |
2023-05-05 |
A
Achat
|
BVF PARTNERS L P/IL
Actionnaire important
|
837 146
0,00
0 USD
|
837 146
|
0,00
|
0 USD
|
|
|
2023-05-09 |
2023-05-05 |
A
Achat
|
BVF PARTNERS L P/IL
Actionnaire important
|
1 055 445
0,00
0 USD
|
1 055 445
|
0,00
|
0 USD
|
|
|
2022-11-23 |
2022-11-23 |
A
Achat
|
Perrin Steven
President
Administrateur exécutif
|
1 000
+inf%
2,60
2 597 USD
|
1 000
+inf%
|
2,60
|
2 597 USD
|
|
|
2021-12-21 |
2021-12-20 |
A
Achat
|
Gros David-Alexandre C
Chief Executive Officer
Administrateur exécutif
|
2 000
+28.6%
4,48
8 960 USD
|
2 000
+28.6%
|
4,48
|
8 960 USD
|
|
|
2021-06-14 |
2021-06-11 |
A
Achat
|
Little Paul Sean
CHIEF FINANCIAL OFFICER
Dirigeant
|
10 000
+inf%
8,87
88 700 USD
|
10 000
+inf%
|
8,87
|
88 700 USD
|
|
|
2021-06-10 |
2021-06-09 |
A
Achat
|
Gros David-Alexandre C
Chief Executive Officer
Administrateur exécutif
|
3 000
+inf%
8,01
24 030 USD
|
3 000
+inf%
|
8,01
|
24 030 USD
|
|
|
2020-12-04 |
2020-12-02 |
V
Vente
|
OrbiMed Israel GP Ltd.
Actionnaire important
|
103 200
-58.4%
21,60
2 229 120 USD
|
103 200
-58.4%
|
21,60
|
2 229 120 USD
|
|
|
2020-11-06 |
2020-10-30 |
A
Achat
|
Logos Global Management LP
Actionnaire important
|
9 098
+4.2%
25,55
232 460 USD
|
9 098
+4.2%
|
25,55
|
232 460 USD
|
|
|
2020-11-06 |
2020-10-30 |
A
Achat
|
Logos Global Management LP
Actionnaire important
|
15 000
+7.5%
26,17
392 610 USD
|
15 000
+7.5%
|
26,17
|
392 610 USD
|
|
|
2020-11-06 |
2020-10-30 |
V
Vente
|
Logos Global Management LP
Actionnaire important
|
27
-0.0%
27,02
730 USD
|
27
-0.0%
|
27,02
|
730 USD
|
|
|
2020-11-06 |
2020-10-30 |
A
Achat
|
Logos Global Management LP
Actionnaire important
|
12 942
+6.9%
25,88
334 926 USD
|
12 942
+6.9%
|
25,88
|
334 926 USD
|
|
|
2020-11-06 |
2020-10-30 |
V
Vente
|
Logos Global Management LP
Actionnaire important
|
12 942
-6.5%
26,64
344 829 USD
|
12 942
-6.5%
|
26,64
|
344 829 USD
|
|
|
2020-11-06 |
2020-10-30 |
A
Achat
|
Logos Global Management LP
Actionnaire important
|
15 000
+8.1%
26,48
397 236 USD
|
15 000
+8.1%
|
26,48
|
397 236 USD
|
|
|
2020-11-06 |
2020-10-30 |
A
Achat
|
Logos Global Management LP
Actionnaire important
|
4 000
+2.2%
25,97
103 892 USD
|
4 000
+2.2%
|
25,97
|
103 892 USD
|
|
|
2020-11-06 |
2020-10-30 |
A
Achat
|
Logos Global Management LP
Actionnaire important
|
31 000
+20.7%
24,53
760 427 USD
|
31 000
+20.7%
|
24,53
|
760 427 USD
|
|
|
2020-11-06 |
2020-10-30 |
A
Achat
|
Logos Global Management LP
Actionnaire important
|
5 000
+3.4%
24,03
120 163 USD
|
5 000
+3.4%
|
24,03
|
120 163 USD
|
|
|
2019-05-22 |
2019-05-21 |
V
Vente
|
FLESHER GREGORY J.
Chief Executive Officer
|
2 937
-1.8%
1,91
5 614 USD
|
2 937
-1.8%
|
1,91
|
5 614 USD
|
|
|
2019-05-22 |
2019-05-21 |
V
Vente
|
Kuwahara Jon
See Remarks
|
1 058
-15.0%
1,91
2 022 USD
|
1 058
-15.0%
|
1,91
|
2 022 USD
|
|
|
2019-05-22 |
2019-05-21 |
V
Vente
|
TURKEL CATHERINE C.
President
|
1 914
-2.1%
1,91
3 658 USD
|
1 914
-2.1%
|
1,91
|
3 658 USD
|
|
|
2019-05-22 |
2019-05-20 |
V
Vente
|
FLESHER GREGORY J.
Chief Executive Officer
|
11 701
-6.8%
1,96
22 953 USD
|
11 701
-6.8%
|
1,96
|
22 953 USD
|
|
|
2019-05-22 |
2019-05-20 |
V
Vente
|
Kuwahara Jon
See Remarks
|
4 218
-37.5%
1,96
8 274 USD
|
4 218
-37.5%
|
1,96
|
8 274 USD
|
|
|
2019-05-22 |
2019-05-20 |
V
Vente
|
TURKEL CATHERINE C.
President
|
7 623
-7.8%
1,96
14 953 USD
|
7 623
-7.8%
|
1,96
|
14 953 USD
|
|
|
2019-05-06 |
2019-05-02 |
A
Achat
|
Chimovits Erez
|
646 204
+25.5%
3,10
2 003 232 USD
|
646 204
+25.5%
|
3,10
|
2 003 232 USD
|
|
|
2019-05-06 |
2019-05-02 |
A
Achat
|
OrbiMed Israel GP Ltd.
Actionnaire important
|
646 204
+25.5%
3,10
2 003 232 USD
|
646 204
+25.5%
|
3,10
|
2 003 232 USD
|
|
|
2019-05-02 |
2019-04-30 |
V
Vente
|
LIFESCI INDEX PARTNERS LLC
Actionnaire important
|
200
-0.0%
2,70
540 USD
|
200
-0.0%
|
2,70
|
540 USD
|
|
|
2018-09-13 |
2018-09-12 |
A
Achat
|
TURKEL CATHERINE C.
President
Dirigeant
|
16 632
+27.0%
5,02
83 476 USD
|
16 632
+27.0%
|
5,02
|
83 476 USD
|
|
|
2018-09-13 |
2018-09-11 |
A
Achat
|
TURKEL CATHERINE C.
President
Dirigeant
|
17 048
+38.3%
4,56
77 671 USD
|
17 048
+38.3%
|
4,56
|
77 671 USD
|
|
|
2018-09-07 |
2018-09-05 |
A
Achat
|
TURKEL CATHERINE C.
President
Dirigeant
|
805
+inf%
3,97
3 193 USD
|
805
+inf%
|
3,97
|
3 193 USD
|
|
|
2017-05-11 |
2017-05-10 |
A
Achat
|
FLESHER GREGORY J.
Chief Executive Officer
Administrateur exécutif
|
58 959
+103.6%
9,99
589 000 USD
|
58 959
+103.6%
|
9,99
|
589 000 USD
|
|
|
2017-05-11 |
2017-05-10 |
A
Achat
|
TURKEL CATHERINE C.
Chief Development Officer
Dirigeant
|
11 111
+82.9%
9,99
110 999 USD
|
11 111
+82.9%
|
9,99
|
110 999 USD
|
|
|
2017-05-11 |
2017-05-10 |
A
Achat
|
OCAMPO CHRISTINE
See Remarks
Dirigeant
|
10 010
+86.4%
9,99
100 000 USD
|
10 010
+86.4%
|
9,99
|
100 000 USD
|
|
|
2016-03-15 |
2016-03-15 |
A
Achat
|
Buckley Stephen Jr.
Administrateur non-exécutif
|
8 000
+266.7%
5,74
45 920 USD
|
8 000
+266.7%
|
5,74
|
45 920 USD
|
|
|
2015-11-12 |
2015-11-11 |
A
Achat
|
Buckley Stephen Jr.
Administrateur non-exécutif
|
3 000
+inf%
11,25
33 750 USD
|
3 000
+inf%
|
11,25
|
33 750 USD
|
|
|
2015-09-22 |
2015-09-21 |
VP
Vente planifiée
|
McBride John S.
Chief Operating Officer
Dirigeant
|
13 500
-100.0%
14,01
189 135 USD
|
13 500
-100.0%
|
14,01
|
189 135 USD
|
|
|
2015-07-30 |
2015-07-29 |
VP
Vente planifiée
|
Morrison Jodie Pope
President and CEO
Administrateur exécutif
|
564
-2.8%
13,70
7 727 USD
|
564
-2.8%
|
13,70
|
7 727 USD
|
|
|
2015-07-30 |
2015-07-28 |
VP
Vente planifiée
|
Morrison Jodie Pope
President and CEO
Administrateur exécutif
|
12 000
-38.0%
13,70
164 400 USD
|
12 000
-38.0%
|
13,70
|
164 400 USD
|
|
|
2015-07-17 |
2015-07-15 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
3 566
-0.1%
14,26
50 844 USD
|
3 566
-0.1%
|
14,26
|
50 844 USD
|
|
|
2015-07-15 |
2015-07-14 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
27 861
-0.6%
14,41
401 477 USD
|
27 861
-0.6%
|
14,41
|
401 477 USD
|
|
|
2015-07-15 |
2015-07-13 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
20 611
-0.5%
14,20
292 717 USD
|
20 611
-0.5%
|
14,20
|
292 717 USD
|
|
|
2015-06-30 |
2015-06-29 |
VP
Vente planifiée
|
Morrison Jodie Pope
President and CEO
Administrateur exécutif
|
8 000
-45.6%
13,70
109 600 USD
|
8 000
-45.6%
|
13,70
|
109 600 USD
|
|
|
2015-06-30 |
2015-06-26 |
VP
Vente planifiée
|
Morrison Jodie Pope
President and CEO
Administrateur exécutif
|
8 000
-45.6%
13,83
110 640 USD
|
8 000
-45.6%
|
13,83
|
110 640 USD
|
|
|
2015-06-24 |
2015-06-24 |
VP
Vente planifiée
|
McBride John S.
Chief Operating Officer
Dirigeant
|
300
-100.0%
14,20
4 260 USD
|
300
-100.0%
|
14,20
|
4 260 USD
|
|
|
2015-06-24 |
2015-06-23 |
VP
Vente planifiée
|
McBride John S.
Chief Operating Officer
Dirigeant
|
6 700
-100.0%
14,00
93 800 USD
|
6 700
-100.0%
|
14,00
|
93 800 USD
|
|
|
2015-06-24 |
2015-06-22 |
VP
Vente planifiée
|
McBride John S.
Chief Operating Officer
Dirigeant
|
2 000
-100.0%
14,02
28 040 USD
|
2 000
-100.0%
|
14,02
|
28 040 USD
|
|
|
2015-06-18 |
2015-06-16 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
1 120
-0.0%
14,27
15 982 USD
|
1 120
-0.0%
|
14,27
|
15 982 USD
|
|
|
2015-06-16 |
2015-06-12 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
5 919
-0.1%
14,20
84 050 USD
|
5 919
-0.1%
|
14,20
|
84 050 USD
|
|
|
2015-06-12 |
2015-06-11 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
27 875
-0.6%
14,20
395 825 USD
|
27 875
-0.6%
|
14,20
|
395 825 USD
|
|
|
2015-03-20 |
2015-03-19 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
46 141
-1.0%
14,50
669 045 USD
|
46 141
-1.0%
|
14,50
|
669 045 USD
|
|
|
2015-03-20 |
2015-03-18 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
3 000
-0.1%
14,50
43 500 USD
|
3 000
-0.1%
|
14,50
|
43 500 USD
|
|
|
2014-09-24 |
2014-09-22 |
A
Achat
|
Apple Tree Partners II - Annex, L.P.
Administrateur non-exécutif
Actionnaire important
|
237 500
+7.1%
15,00
3 562 500 USD
|
237 500
+7.1%
|
15,00
|
3 562 500 USD
|
|
|
2014-09-24 |
2014-09-22 |
A
Achat
|
Novartis Bioventures Ltd
Actionnaire important
|
325 000
+7.5%
15,00
4 875 000 USD
|
325 000
+7.5%
|
15,00
|
4 875 000 USD
|
|
|
2014-09-24 |
2014-09-22 |
A
Achat
|
Harrison Seth Loring
Administrateur non-exécutif
Actionnaire important
|
362 500
+4.8%
15,00
5 437 500 USD
|
362 500
+4.8%
|
15,00
|
5 437 500 USD
|
|
|
2014-09-24 |
2014-09-22 |
A
Achat
|
Satter Muneer A
Actionnaire important
|
150 000
+9.2%
15,00
2 250 000 USD
|
150 000
+9.2%
|
15,00
|
2 250 000 USD
|
|
|
2015-06-16 |
2014-06-15 |
V
Vente
|
Novartis Bioventures Ltd
Actionnaire important
|
14 777
-0.3%
14,20
209 833 USD
|
14 777
-0.3%
|
14,20
|
209 833 USD
|
|
